Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cretin

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 4, 2006
Carboplatin/cyclophosphamide or carboplatin/paclitaxel in elderly patients with advanced ovarian cancer? Analysis of two consecutive trials from the Groupe d'Investigateurs Nationaux pour l'Etude des Cancers OvariensO Trédan, J-F Geay, S Touzet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 27, 2009
Docetaxel and pegylated liposomal doxorubicin combination as first-line therapy for metastatic breast cancer patients: results of the phase II GINECO trial CAPYTTOLEC de la Fouchardière, R Largillier, Y Goubely, et al.
European Journal of Cancer (Oxford, England : 1990)|June 6, 2013
Impact of geriatric risk factors on pegylated liposomal doxorubicin tolerance and efficacy in elderly metastatic breast cancer patients: final results of the DOGMES multicentre GINECO trialC Falandry, E Brain, M Bonnefoy, et al.
British Journal of Cancer|February 5, 2009
Gemcitabine-oxaliplatin combination for ovarian cancer resistant to taxane-platinum treatment: a phase II study from the GINECO groupI Ray-Coquard, B Weber, J Cretin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 22, 2015
Randomized phase III trial in elderly patients comparing LV5FU2 with or without irinotecan for first-line treatment of metastatic colorectal cancer (FFCD 2001-02)T Aparicio, S Lavau-Denes, J M Phelip, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 16, 2008
[Ductal carcinoma in situ: role of the boost]D Azria, H Auvray, I Barillot, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 4, 2006
Carboplatin/cyclophosphamide or carboplatin/paclitaxel in elderly patients with advanced ovarian cancer? Analysis of two consecutive trials from the Groupe d'Investigateurs Nationaux pour l'Etude des Cancers OvariensO Trédan, J-F Geay, S Touzet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 27, 2009
Docetaxel and pegylated liposomal doxorubicin combination as first-line therapy for metastatic breast cancer patients: results of the phase II GINECO trial CAPYTTOLEC de la Fouchardière, R Largillier, Y Goubely, et al.
European Journal of Cancer (Oxford, England : 1990)|June 6, 2013
Impact of geriatric risk factors on pegylated liposomal doxorubicin tolerance and efficacy in elderly metastatic breast cancer patients: final results of the DOGMES multicentre GINECO trialC Falandry, E Brain, M Bonnefoy, et al.
British Journal of Cancer|February 5, 2009
Gemcitabine-oxaliplatin combination for ovarian cancer resistant to taxane-platinum treatment: a phase II study from the GINECO groupI Ray-Coquard, B Weber, J Cretin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 22, 2015
Randomized phase III trial in elderly patients comparing LV5FU2 with or without irinotecan for first-line treatment of metastatic colorectal cancer (FFCD 2001-02)T Aparicio, S Lavau-Denes, J M Phelip, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 16, 2008
[Ductal carcinoma in situ: role of the boost]D Azria, H Auvray, I Barillot, et al.
Pageof 1